13-cis-Retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma

J. M. Chow, A. L. Cheng, I. J. Su, C. H. Wang

研究成果: 雜誌貢獻文章同行評審

22 引文 斯高帕斯(Scopus)

摘要

A 35-year-old man with refractory cutaneous Ki-1 lymphoma was salvaged successfully with oral 13-cis-retinoic acid (1 mg/kg/day). He had a complete remission lasting for 20 months before a single nodule recurred on his skin. Excisional biopsy of the recurrent tumor revealed a distinct morphologic change, suggesting cellular differentiation toward a more benign phenotype. No significant side effects were noted except mild xerostomia, bone pain, and hyperlipidemia. The authors believe that 13-cis-retinoic acid should be considered in the treatment of cutaneous Ki-1 lymphoma.

原文英語
頁(從 - 到)2490-2494
頁數5
期刊Cancer
67
發行號10
出版狀態已發佈 - 1991
對外發佈Yes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

指紋 深入研究「13-cis-Retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma」主題。共同形成了獨特的指紋。

引用此